首页> 美国卫生研究院文献>Diabetes Care >Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial

【2h】

Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial

机译：利拉鲁肽3.0 mg在超重或肥胖个体和基础胰岛素治疗的2型糖尿病患者中的疗效和安全性：SCALE胰岛素随机对照试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Diabetes Care
作者
W. Timothy Garvey; Andreas L. Birkenfeld; Dror Dicker; Geltrude Mingrone; Sue D. Pedersen; Altynai Satylganova; Dorthe Skovgaard; Danny Sugimoto; Camilla Jensen; Ofri Mosenzon;
展开▼
作者单位

展开▼
年(卷),期 2020(43),5
年度 2020
页码 -1
总页数 9
原文格式 PDF
正文语种
中图分类护理学;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial [J] . Diabetes care . 2020,第5期

机译：Liraglutide 3.0毫克在具有超重或肥胖的个体中的疗效和安全性，并用基础胰岛素治疗2型糖尿病：规模胰岛素随机对照试验
2. Safety and Efficacy of High Versus Standard Starting Doses of Insulin Glargine in Overweight and Obese Chinese Individuals with Type 2 Diabetes Mellitus Inadequately Controlled on Oral Antidiabetic Medications (Beyond VII): Study Protocol for a Randomized Controlled Trial [J] . Linong Ji, Zhengnan Gao, Bimin Shi, Advances in therapy. . 2018,第6期

机译：高重和肥胖中胰岛素狼人的高重和肥胖的药物的安全性和有效性在口腔抗糖尿病药物（超越VII之外）中的2型糖尿病中的胰腺炎患者：用于随机对照试验的研究方案
3. Durable efficacy of liraglutide in patients with type 2 diabetes and pronounced insulin-associated weight gain: 52-week results from the Effect of Liraglutide on insulin-associated wEight GAiN in patients with Type 2 diabetes' (ELEGANT) randomized controlled trial [J] . de Wit H. M., Vervoort G. M., Jansen H. J., Journal of Internal Medicine . 2016,第3期

机译：利拉鲁肽对2型糖尿病患者的持久疗效和明显的胰岛素相关体重增加：利拉鲁肽对2型糖尿病患者胰岛素相关权重GAiN的影响52周的结果（ELEGANT）随机对照试验
4. Comparing artificial pancreas controlled by hybrid "closed-loop" machine learning (ML) trained algorithm to multi-daily injection (MDI), insulin pump without CGM and "sensor assisted" insulin pump therapies for Diabetes Type 1 (DT1) treatment [C] . Joan Carles Peiró International Conference on Data Analytics for Business and Industry: Way Towards a Sustainable Economy . 2020

机译：将通过混合“闭环”机器学习（ML）控制的人工胰腺培训算法对多日注于多日注射（MDI），胰岛素泵而没有CGM和“传感器辅助”胰岛素泵疗法1型（DT1）处理
5. A 4-month randomized controlled clinical trial of adjuvant Exenatide or Pramlintide versus insulin alone in pediatric type 1 diabetes mellitus: Effect on glycemic control. [D] . Withycombe, Sarah Elizabeth. 2010

机译：儿科1型糖尿病患者中艾塞那肽或普兰林肽与单独使用胰岛素的4个月随机对照临床试验：对血糖控制的影响。
6. Safety and Efficacy of High Versus Standard Starting Doses of Insulin Glargine in Overweight and Obese Chinese Individuals with Type 2 Diabetes Mellitus Inadequately Controlled on Oral Antidiabetic Medications (Beyond VII): Study Protocol for a Randomized Controlled Trial [O] . Linong Ji, Zhengnan Gao, Bimin Shi, -1

机译：在口服抗糖尿病药控制不佳的超重和肥胖中国2型糖尿病患者中高甘露糖胰岛素相对于标准开始剂量的安全性和有效性：一项随机对照试验的研究方案
7. Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal–bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial [O] . Bartley, P C, Bogoev, M, Larsen, J, 2008

机译：使用针对目标的基础推注方案和餐前胰岛素门冬胰岛素治疗，地特胰岛素与中性鱼精蛋白哈格多恩胰岛素相比具有长期疗效和安全性：一项为期2年的随机对照试验

Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial

著录项

相似文献

相关主题

期刊订阅